Table 2.
Prevention strategies for postoperative pulmonary complications.
Options | Proposed mechanisms | |
---|---|---|
Mechanical factors | Miniaturized CPB circuit | Decrease contact activation, decreased hemodilution |
Coated CPB circuit (heparin, PMEA) | Decrease contact activation | |
Leukocyte filtration | Remove activated leukocytes, especially for longer CPB duration | |
Retrograde autologous priming (RAP) | Decrease hemodilution | |
Ultrafiltration (modified, zero-balance) | Hemoconcentration, filtration of mediators | |
Normoxia on CPB | Reduce reperfusion injury with free oxygen radicals | |
Surgical technique | Avoid CPB if possible | |
Reduce the duration of time on CPB | Reduction in time available for inflammation/ischemic injury to lungs | |
Cardioprotection with cardioplegia | Prevent ischemia–reperfusion injury | |
Minimize cardiotomy suction | Decrease blood–air contact; decrease activation of inflammatory response | |
Transfusion-sparing techniques | Decrease inflammation/immune responses to transfusion | |
Partial lung perfusion | Decrease ischemia to lungs, more complicated surgical procedure | |
Anesthesia factors | Intermittent ventilation | Prevent atelectasis |
Recruitment maneuver | Reduce atelectasis, improve respiratory mechanics, reduce volutrauma | |
Low tidal volume ventilation | Prevent shear stress, various types of trauma to lungs: volutrauma, barotraumas, and atelectatrauma | |
Volatile anesthesia-based | ||
Medications | Steroids | Modulate immune response, potential negative impact on glucose control and wound healing |
Neutrophil elastase inhibitors | Inhibit neutrophil elastase and reduce leukocyte sequestration in the lungs | |
Hypertonic saline | Decrease extravascular lung water, improve oxygenation | |
Aprotonin | Decrease extravascular lung water, improve oxygenation, and reduce neutrophil sequestration |